Aggrenox®

CHARISMA

Secondary Endpoint (CV Death, MI, Stroke, Hospitalisation)

References

Bhatt et al. The Main Results of the CHARISMA Trial. Oral Presentation 402-10. ACC 2006. 12 March 2006

previous 1|2|3|4|5|6|7 next